Provecs Medical Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Out of Business

Provecs Medical General Information

Description

Developer of a proprietary enviro adenoviral platform intended to provide novel treatment options for patients with advanced cancers and infectious diseases. The company's platform leverages technology to develop a versatile and cost-effective platform that locally delivers bio-molecules known to be non-tolerable in systemic use or impossible to manufacture, such as membrane proteins, short-lived cytokines, enabling clients to get access to tumor gene therapy to expose the tumor to the immune system.

Contact Information

Website
www.provecs.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Martinistraße 64
  • 20251 Hamburg
  • Germany
+49 040 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Provecs Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Aug-2020 Completed Out of Business
3. Secondary Transaction - Private 28-Jul-2015 Completed Generating Revenue
2. Angel (individual) 01-Jan-2010 Completed Startup
1. Seed Round 03-Aug-2007 Completed Startup
To view Provecs Medical’s complete valuation and funding history, request access »

Provecs Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial